Covered recipient · General Payments record
TEANDRA R DARDEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2023
$4,840.93
- Reported across 207 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $867.13 | 36 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $362.66 | 17 |
| Amgen Inc. | $243.45 | 6 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.21 | 2 |
| Acerta Pharma LLC | $42.86 | 2 |
| PFIZER INC. | $37.68 | 2 |
| Actelion Pharmaceuticals US, Inc. | $31.29 | 1 |
| Horizon Pharma plc | $28.18 | 1 |
| Janssen Biotech, Inc. | $21.60 | 1 |
| Medtronic, Inc. | $16.15 | 1 |
| Sandoz Inc. | $15.23 | 1 |
| Organon LLC | $12.82 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (36)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.01 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592911 | CMS |
| ABBVIE INC. | $25.00 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592917 | CMS |
| ABBVIE INC. | $20.24 | 01/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592925 | CMS |
| ABBVIE INC. | $23.52 | 01/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592931 | CMS |
| ABBVIE INC. | $29.69 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592939 | CMS |
| ABBVIE INC. | $28.08 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592949 | CMS |
| ABBVIE INC. | $25.80 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592955 | CMS |
| ABBVIE INC. | $26.22 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592961 | CMS |
| ABBVIE INC. | $26.00 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592969 | CMS |
| ABBVIE INC. | $21.63 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592975 | CMS |
| ABBVIE INC. | $17.11 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592983 | CMS |
| ABBVIE INC. | $16.13 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003592995 | CMS |
| ABBVIE INC. | $16.75 | 07/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003593001 | CMS |
| ABBVIE INC. | $22.18 | 08/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003593009 | CMS |
| ABBVIE INC. | $4.11 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003593015 | CMS |
| ABBVIE INC. | $18.68 | 11/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003593021 | CMS |
| ABBVIE INC. | $18.51 | 12/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003593027 | CMS |
| Actelion Pharmaceuticals US, Inc. | $31.29 | 05/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988491561 | CMS |
| Amgen Inc. | $19.54 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515387 | CMS |
| Amgen Inc. | $24.90 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515381 | CMS |
| Amgen Inc. | $22.49 | 02/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515379 | CMS |
| Amgen Inc. | $32.15 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515383 | CMS |
| Amgen Inc. | $25.61 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515385 | CMS |
| Amgen Inc. | $118.76 | 09/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020515377 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.03 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1011328855 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.83 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014671497 | CMS |
| Horizon Therapeutics plc | $28.18 | 10/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 987098601 | CMS |
| Janssen Biotech, Inc. | $21.60 | 02/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988381811 | CMS |
| Medtronic, Inc. | $16.15 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019451959 | CMS |
| Novartis Pharmaceuticals Corporation | $24.25 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991711127 | CMS |
| Novartis Pharmaceuticals Corporation | $30.96 | 05/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991711131 | CMS |
| Organon LLC | $0.47 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046945539 | CMS |
| Organon LLC | $12.35 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046945549 | CMS |
| PFIZER INC. | $17.86 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049147433 | CMS |
| PFIZER INC. | $19.82 | 10/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050071103 | CMS |
| Sandoz Inc. | $15.23 | 10/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1028934435 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.